1. AstraZeneca quits cancer pipeline efforts — Eisai's weight loss drug is pulled from market due to safety concerns — Melinta seeks buyout bids to escape bankruptcy — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Is the Madsen case a watershed for Nuvasive?

Discussion in 'NuVasive' started by anonymous, Mar 3, 2016 at 2:31 PM.

  1. anonymous

    anonymous Guest

  2. anonymous

    anonymous Guest

    GOOD FOR HER! It is about time the spine companies get hammered in court for poaching business.

    Couldn't happen to a sleazier industry! The whore surgeons should be next!

    Thanks doc for the one level L2-L3 fusion...should I schedule now for the revision and inevitable fusion(s) of all the adjacent levels?